Axonics Debt to Equity Ratio 2017-2023 | AXNX
Axonics Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2023-12-31 | $0.08B | $0.64B | 0.13 |
2023-09-30 | $0.05B | $0.61B | 0.08 |
2023-06-30 | $0.05B | $0.60B | 0.08 |
2023-03-31 | $0.09B | $0.58B | 0.15 |
2022-12-31 | $0.09B | $0.57B | 0.16 |
2022-09-30 | $0.08B | $0.55B | 0.15 |
2022-06-30 | $0.08B | $0.44B | 0.17 |
2022-03-31 | $0.06B | $0.46B | 0.13 |
2021-12-31 | $0.07B | $0.48B | 0.14 |
2021-09-30 | $0.07B | $0.49B | 0.15 |
2021-06-30 | $0.06B | $0.50B | 0.12 |
2021-03-31 | $0.12B | $0.33B | 0.35 |
2020-12-31 | $0.06B | $0.29B | 0.19 |
2020-09-30 | $0.05B | $0.29B | 0.18 |
2020-06-30 | $0.05B | $0.30B | 0.17 |
2020-03-31 | $0.05B | $0.17B | 0.26 |
2019-12-31 | $0.04B | $0.18B | 0.20 |
2019-09-30 | $0.03B | $0.09B | 0.37 |
2019-06-30 | $0.03B | $0.11B | 0.28 |
2019-03-31 | $0.03B | $0.13B | 0.21 |
2018-12-31 | $0.03B | $0.14B | 0.20 |
2018-09-30 | $0.02B | $0.02B | 0.74 |
2018-06-30 | $0.00B | $0.00B | 0.00 |
2018-03-31 | $0.00B | $0.00B | 0.00 |
2017-12-31 | $0.00B | 0.00 | |
2017-09-30 | $0.00B | $0.00B | 0.00 |
2016-12-31 | $0.00B | $0.01B | 0.20 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $3.514B | $0.366B |
Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $41.123B | 22.92 |
Inspire Medical Systems (INSP) | United States | $6.468B | 0.00 |
10x Genomics (TXG) | United States | $4.396B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.586B | 0.00 |
Enovis (ENOV) | United States | $3.425B | 26.02 |
Hims & Hers Health (HIMS) | United States | $3.372B | 0.00 |
Azenta (AZTA) | United States | $3.314B | 270.14 |
Olink Holding AB (publ) (OLK) | Sweden | $2.934B | 0.00 |
Privia Health (PRVA) | United States | $2.318B | 102.89 |
Schrodinger (SDGR) | United States | $1.926B | 0.00 |
Phreesia (PHR) | United States | $1.375B | 0.00 |
Omnicell (OMCL) | United States | $1.343B | 32.85 |
Definitive Healthcare (DH) | United States | $0.931B | 0.00 |
Standard BioTools (LAB) | United States | $0.780B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
Talkspace (TALK) | United States | $0.603B | 0.00 |
Health Catalyst (HCAT) | United States | $0.436B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.393B | 0.00 |
Pulmonx (LUNG) | United States | $0.351B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.343B | 0.00 |
P3 Health Partners (PIII) | United States | $0.319B | 0.00 |
American Well (AMWL) | United States | $0.249B | 0.00 |
Butterfly Network (BFLY) | United States | $0.221B | 0.00 |
Augmedix (AUGX) | United States | $0.197B | 0.00 |
TruBridge (TBRG) | United States | $0.139B | 5.97 |
Outset Medical (OM) | United States | $0.111B | 0.00 |
MSP Recovery (LIFW) | United States | $0.097B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.091B | 0.00 |
111 (YI) | China | $0.084B | 0.00 |
Future Health ESG (FHLT) | United States | $0.064B | 0.00 |
Zepp Health (ZEPP) | China | $0.063B | 0.00 |
HeartBeam (BEAT) | United States | $0.058B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.041B | 0.00 |
Cue Health (HLTH) | United States | $0.029B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.027B | 0.00 |
Akili (AKLI) | United States | $0.023B | 0.00 |
Movano (MOVE) | United States | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
ETAO (ETAO) | United States | $0.020B | 0.00 |
CareCloud (CCLD) | United States | $0.019B | 0.00 |
Centogene (CNTG) | Germany | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.016B | 0.00 |
Syra Health (SYRA) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
Predictive Oncology (POAI) | United States | $0.011B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Heart Test Laboratories (HSCS) | United States | $0.008B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Motus GI Holdings (MOTS) | United States | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |